Snider Financial Group Bausch Health Companies Inc. Transaction History

Snider Financial Group

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$7.06 - $23.63 $76,269 - $255,274	10,803 Added 97.48%	21,885 $183,000
Q1 2022 May 13, 2022	BUY	$21.6 - $27.79 $4,622 - $5,947	214 Added 1.97%	11,082 $253,000
Q4 2021 Jan 18, 2022	BUY	$23.0 - $29.01 $9,913 - $12,503	431 Added 4.13%	10,868 $302,000
Q3 2021 Nov 05, 2021	BUY	$25.04 - $30.06 $7,136 - $8,567	285 Added 2.81%	10,437 $293,000
Q2 2021 Aug 31, 2021	BUY	$27.43 - $32.7 $278,469 - $331,970	10,152 New	10,152 $280,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Snider Financial Group, based on Form 13F filings with the SEC.

Stay updated on Snider Financial Group with notifications on news.